Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.

Brain pathology (Zurich, Switzerland) - 1 Apr 2002

Hartmann Christian, Johnk Loki, Sasaki Hikaru, Jenkins Robert B, Louis David N

Abstract excerpt

PLA2G4C, encoding cytosolic phospholipase A2-gamma (cPLA2-gamma), is a 17-exon gene located on chromosome 19q13.3 within the putative glioma tumor suppressor gene region. Given the clinical importance of assessing 1p and 19q loss in human gliomas, the development of convenient and practical assays for detecting allelic loss is of considerable priority in neuro-oncology. We report a minisatellite polymorphism in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosomes, Human, Pair 19

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Loss of Heterozygosity

Share to Phospholipases A

Share to Phospholipases A2

Share to Polymorphism, Genetic

Share to Repetitive Sequences, Nucleic Acid

Source

Open in PubMed Open full text

Identifiers

PMID: 11958371
DOI: 10.1111/j.1750-3639.2002.tb00432.x
PMCID: PMC8095768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel PLA2G4C polymorphism as a molecular diagnostic assay for 19q loss in human gliomas.PMID 11958371Read ↗

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeSemantic proximity Read ↗

Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of Gliomas.Semantic proximity Read ↗

FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice – a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Semantic proximity Read ↗

Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profilingSemantic proximity Read ↗

Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomasSemantic proximity Read ↗

Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis.Semantic proximity Read ↗

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomasSemantic proximity Read ↗

Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas.Semantic proximity Read ↗

Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort.Semantic proximity Read ↗

A custom next-generation sequencing panel for 1p/19q codeletion and mutational analysis in gliomas.Semantic proximity Read ↗

Deletion mapping of chromosome 19 in human gliomasSemantic proximity Read ↗

Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.